721 Ongoing phase 1 study of MP0317, a FAP-CD40 DARPin, shows a favorable safety profile and early evidence of tumor-localized CD40 activation in patients with advanced solid tumors

Gelijkaardige items

• PTT-Mediated Inhibition of Cancer Proliferation and Tumor Progression by DARPin-Coated Gold Nanoparticles
  door: Galina M. Proshkina, et al.
  Gepubliceerd in: (2025-01-01)
• 721 Ongoing phase 1 study of MP0317, a FAP-CD40 DARPin, shows a favorable safety profile and early evidence of tumor-localized CD40 activation in patients with advanced solid tumors
  door: Anne Goubier, et al.
  Gepubliceerd in: (2023-11-01)
• Development of DARPin T cell engagers for specific targeting of tumor-associated HLA/peptide complexes
  door: Natalia Venetz-Arenas, et al.
  Gepubliceerd in: (2025-12-01)
• A Multispecific Checkpoint Inhibitor Nanofitin with a Fast Tumor Accumulation Property and Anti-Tumor Activity in Immune Competent Mice
  door: Perrine Jacquot, et al.
  Gepubliceerd in: (2025-03-01)
• Coxiella burnetii Nine Mile II Δcbu0533 as a suitable laboratory replacement strain
  door: Kathleen N. Pierce, et al.
  Gepubliceerd in: (2026-01-01)